Medicine Lodge Memorial Hospital - Medicare Critical Access Hospital in Medicine Lodge, KS

Medicine Lodge Memorial Hospital is a medicare enrolled Critical Access Hospital in Medicine Lodge, Kansas. It is located at 710 N Walnut Street, Medicine Lodge, Kansas 67104. You can reach out to the office of Medicine Lodge Memorial Hospital via phone at (620) 886-3771.

The ownership type of Medicine Lodge Memorial Hospital is Government - Hospital District or Authority and it provides emergency services (Emergency Room). The Medicare ID (also called CCN - CMS Certification Number) for Medicine Lodge Memorial Hospital is 171334.

Contact Information

Medicine Lodge Memorial Hospital
710 N Walnut Street, Medicine Lodge, Kansas 67104
(620) 886-3771
Not Available

Hospital Profile

NameMedicine Lodge Memorial Hospital
TypeCritical Access Hospital
Location710 N Walnut Street, Medicine Lodge, Kansas
OwnershipGovernment - Hospital District or Authority
Emergency ServicesYes
Medicare ID (CCN)171334

Patients' Experience Survey:


NPI Associated with the Hospital:

Unlike individual providers, Hospitals may have multiple NPI numbers for example, there can be a separate NPI for each unit within the hospital. We have found possible NPI number/s associated with Medicine Lodge Memorial Hospital from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1407887193
Organization NameMEDICINE LODGE MEMORIAL HOSPITAL
Address701 N Walnut St, Drawer 'c', Medicine Lodge, KS 67104
Hospital TypeGeneral Acute Care Hospital - Critical Access
Phone Number620-886-3771

News Archive

FDA grants orphan drug designation to ERYTECH's lead product for AML treatment

ERYTECH Pharma, a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet medical needs, announces that its lead product GRASPA®/ERY-ASP has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of Acute Myeloid Leukemia (AML), an aggressive form of blood cancer.

Amphion Innovations reports interim results for the six months ended 30 June 2009

Amphion Innovations plc (LSE: AMP) ("Amphion" or the "Company"), the developer of medical and technology businesses, today announces its unaudited interim results for the six months to 30 June 2009.

Improved mood linked with improved brain rehabilitations outcomes

Mayo Clinic researchers found that improvement of mood over the course of post-acute brain rehabilitation is associated with increased participation in day-to-day activities, independent living, and ability to work after rehabilitation is complete.

Haemonetics net revenue increases 8% to $235.8 million in Q2 fiscal 2014

Haemonetics Corporation today reported second quarter fiscal 2014 net revenue of $235.8 million, up 8%, GAAP net income of $16.5 million and earnings per share of $0.32. Adjusted net income, exclusive of transformation, integration and deal amortization expenses detailed below, was $34.4 million, up 24%, and adjusted earnings per share were $0.66, up 24%. Excluding currency impact, net revenue was up 11% in the quarter.

Researchers identify molecular switch that can avoid inflammation

Our immune system is vital to us and can sometimes overreact causing chronic illnesses, such as for instance rheumatism and allergy. Now, researchers from Umeå University and University of Gothenburg have identified a molecular switch - MYSM1 - that can suppress such an overreaction and avoid inflammation.

Read more Medical News

› Verified 5 days ago


Structural Quality Measures:

Able to receive lab results electronicallyYes
Able to track patients' lab results, tests, and referrals electronically between visitsYes

News Archive

FDA grants orphan drug designation to ERYTECH's lead product for AML treatment

ERYTECH Pharma, a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet medical needs, announces that its lead product GRASPA®/ERY-ASP has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of Acute Myeloid Leukemia (AML), an aggressive form of blood cancer.

Amphion Innovations reports interim results for the six months ended 30 June 2009

Amphion Innovations plc (LSE: AMP) ("Amphion" or the "Company"), the developer of medical and technology businesses, today announces its unaudited interim results for the six months to 30 June 2009.

Improved mood linked with improved brain rehabilitations outcomes

Mayo Clinic researchers found that improvement of mood over the course of post-acute brain rehabilitation is associated with increased participation in day-to-day activities, independent living, and ability to work after rehabilitation is complete.

Haemonetics net revenue increases 8% to $235.8 million in Q2 fiscal 2014

Haemonetics Corporation today reported second quarter fiscal 2014 net revenue of $235.8 million, up 8%, GAAP net income of $16.5 million and earnings per share of $0.32. Adjusted net income, exclusive of transformation, integration and deal amortization expenses detailed below, was $34.4 million, up 24%, and adjusted earnings per share were $0.66, up 24%. Excluding currency impact, net revenue was up 11% in the quarter.

Researchers identify molecular switch that can avoid inflammation

Our immune system is vital to us and can sometimes overreact causing chronic illnesses, such as for instance rheumatism and allergy. Now, researchers from Umeå University and University of Gothenburg have identified a molecular switch - MYSM1 - that can suppress such an overreaction and avoid inflammation.

Read more News

› Verified 5 days ago

Hospitals in Medicine Lodge, KS

Medicine Lodge Memorial Hospital
Critical Access Hospital
Location: 710 N Walnut Street, Medicine Lodge, Kansas 67104
Phone: (620) 886-3771    

Medicare Hospital Compare

Hospital Compare provide information about the quality of care at over 4,000 Medicare-certified hospitals across the country. You can use Hospital Compare to find hospitals and compare the quality of their care. The information on Hospital Compare:
  • Helps you make decisions about where you get your health care
  • Encourages hospitals to improve the quality of care they provide
In an emergency, you should go to the nearest hospital. When you can plan ahead, discuss the information you find here with your health care provider to decide which hospital will best meet your health care needs. Hospital Compare was created through the efforts of the Centers for Medicare & Medicaid Services (CMS), in collaboration with organizations representing consumers, hospitals, doctors, employers, accrediting organizations, and other federal agencies.

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.